- QMRO Home
- William Harvey Research Institute
- Centre for Translational Medicine & Therapeutics
- Rituximab and Tocilizumab and Their Effect on Lung Disease Progression in Scleroderma. a Retrospective Cohort Study at a Single Centre
Browse
Administrators only